A separate model constructed solely using the TNFRI/TNFRII ratio revealed an odds ratio of 3.974 for an unfavorable outcome in a COVID-19 patient (OR = 3.974; CI = 2.070 to 7.628, p < 0.001). This evidence concerns the gene TNFRSF1A and COVID-19.